HLB Life Science Co., Ltd. (KOSDAQ:067630)
3,105.00
+130.00 (4.37%)
Jun 9, 2026, 3:30 PM KST
-47.01% (1Y)
| Market Cap | 362.50B -53.5% |
| Revenue (ttm) | 51.51B +46.5% |
| Net Income | -50.45B |
| EPS | -413.72 |
| Shares Out | 121.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 247,535 |
| Open | 2,975.00 |
| Previous Close | 2,975.00 |
| Day's Range | 2,975.00 - 3,180.00 |
| 52-Week Range | 2,960.00 - 6,020.00 |
| Beta | -0.03 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |